Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open-label, active-controlled, 12-week study (STABLE II study)
about
Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open-label, active-controlled, 12-week study (STABLE II study)
description
scientific article published on 17 October 2019
@en
name
Comparison of the effects of g ...... 2-week study (STABLE II study)
@en
type
label
Comparison of the effects of g ...... 2-week study (STABLE II study)
@en
prefLabel
Comparison of the effects of g ...... 2-week study (STABLE II study)
@en
P2093
P50
P356
P1476
Comparison of the effects of g ...... 2-week study (STABLE II study)
@en
P2093
Eun Young Lee
Hyun Jin Kim
Ji Cheol Bae
Jong Chul Won
Sang-Yong Kim
Soo Heon Kwak
P304
P356
10.1111/DOM.13882
P577
2019-10-17T00:00:00Z